by Chris Thurstone | Mar 18, 2016 | Marijuana, Research
The news from London-based GW Pharmaceuticals is worth celebrating: Epidiolex — purified, pharmacy-grade and nonintoxicating cannabidiol extracted from the cannabis plant — has both Orphan Drug Designation and Fast Track Designation from the U.S. Food and...
by Christine Tatum | Dec 10, 2015 | Marijuana, Research
This week’s annual meeting of the American Epilepsy Society has included the presentation and discussion of several papers about Epidiolex, a purified CBD oil produced by GW Pharmaceuticals. Epidiolex, which is now in clinical trials, is widely considered among...
by Chris Thurstone | Jun 26, 2014 | Public Policy, Research, Uncategorized
First, please let me be clear: I want more research of Cannabidiol, the nonintoxicating component of the cannabis plant that has shown some medical promise — particularly for the treatment of children with intractable epilepsy. I want that research to comply...
by Chris Thurstone | Jun 3, 2014 | Public Policy, Research, Uncategorized
The states of Georgia and New York have moved boldly to become national leaders in the responsible development of pharmacy-grade medication made from components of the cannabis plant. Last week, the State of Georgia, working in collaboration with the U.S. Food and...